Standard Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-609
Closed -$197K 245
2022
Q3
$197K Buy
+609
New +$193K 0.09% 37
2021
Q4
Sell
-652
Closed -$151K 231
2021
Q3
$151K Sell
652
-4,136
-86% -$1.02M 0.04% 13
2021
Q2
$1.1M Buy
4,788
+652
+16% +$131K 0.23% 39
2021
Q1
$773K Sell
4,136
-652
-14% -$128K 0.18% 45
2020
Q4
$808K Buy
+4,788
New +$715K 0.19% 39

Other funds holding LLY

Standard Family Office's LLY Position: Q4 2022 in Review

Standard Family Office sold out of Eli Lilly (LLY) in Q4 2022, closing a stake of 609 shares — an estimated $197K sold.

Standard Family Office first reported a position in LLY in Q4 2020 and held it in 5 quarters. The position peaked at $1.1M in Q2 2021. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Standard Family Office reported no remaining Eli Lilly position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 609 Eli Lilly shares in Q4 2022, an estimated $197K.
  • Standard Family Office first reported a position in Eli Lilly in Q4 2020 and held it in 5 quarters.
  • Standard Family Office's Eli Lilly position peaked at $1.1M in Q2 2021.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.